drugset / Trial / NCT00656643
Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of an ocular sirolimus (rapamycin) formulation at various doses in patients with diabetic macular edema.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-11
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 220 ug | Other |
| Subject | Sirolimus | Small molecule | 440 ug | Other |
| Subject | Sirolimus | Small molecule | 880 ug | Other |